WHAT IS KNOWN ABOUT THE TOPIC?
- –
Stent thrombosis is a dreaded complication after percutaneous coronary revascularization due to its high lethality. However, its incidence is currently low with the use of bare-metal stents and new-generation DESs. In addition, a reduced ST rate has been found with both ticagrelor and prasugrel vs clopidogrel.
WHAT DOES THIS STUDY ADD?
- –
Beyond the pivotal clinical trials (PLATO and TRITON-TIMI), little is known about the incidence and predictors of ST